SOCS1 and acute lymphoblastic leukemia: One study refers the reduction in miR-155 level in ALL patients compared to controls; particularly, miR-155 can act as a modulator of Treg cells differentiation by targeting Suppressor Of Cytokine Signaling 1 (SOCS1) [36].